Envista Holdings Corp (STU:0HV)
€ 21 0 (0%) Market Cap: 3.63 Bil Enterprise Value: 4.18 Bil PE Ratio: 0 PB Ratio: 1.25 GF Score: 73/100

Envista Holdings Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 16, 2020 / 08:15PM GMT
Release Date Price: €22.2 (+2.78%)
David Ryan Lewis
Morgan Stanley, Research Division - MD

Well, good afternoon and welcome to the Morgan Stanley Healthcare Conference 2020, and thanks for joining us here on day 3 of our coverages and progressing through the rest of the week. It's my pleasure to have with us here, rounding out the afternoon, Envista, who you all know, is a leading provider -- in fact, the leading provider of dental products globally. It's my pleasure to have multiple members of management team with us here today, Amir Aghdaei, the CEO; Howard Yu, CFO; and John Bedford, VP of Investor Relations. So we're going to get right after it.

Questions & Answers

David Ryan Lewis
Morgan Stanley, Research Division - MD

And Amir, I want to start with a theme that has sort of emerged throughout the broader conference, which is recovery. And dental recovery has been a little different than classic implantable medical device recovery. But that said, there's still recovery. Maybe just help us understand what you're seeing as it relates to dental recovery here in the third quarter as

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot